CN110041294A - The synthetic method and its application of the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide - Google Patents

The synthetic method and its application of the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide Download PDF

Info

Publication number
CN110041294A
CN110041294A CN201910394987.2A CN201910394987A CN110041294A CN 110041294 A CN110041294 A CN 110041294A CN 201910394987 A CN201910394987 A CN 201910394987A CN 110041294 A CN110041294 A CN 110041294A
Authority
CN
China
Prior art keywords
chloro
furyl
hydroxyethyl
bis
acetamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910394987.2A
Other languages
Chinese (zh)
Inventor
张越
韩晓蕾
郭庆春
吕海军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hebei University of Science and Technology
Original Assignee
Hebei University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hebei University of Science and Technology filed Critical Hebei University of Science and Technology
Priority to CN201910394987.2A priority Critical patent/CN110041294A/en
Publication of CN110041294A publication Critical patent/CN110041294A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N2030/022Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027Liquid chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention discloses one kind 2; the synthetic method and its application of the chloro- N- of 2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide; synthetic method therein is that acylation reaction occurs under alkaline condition with dichloroacetyl chloride and is made using α-(amino methyl) -2- furancarbinol as raw material.Synthetic method provided by the present invention is easy to operate, process is easily controllable, gained 2, and the yield of the chloro- N- of 2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide is 60~80%, it can be used as standard items, for detecting and monitoring the synthesis of furilazole.

Description

The synthetic method of the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide And its application
Technical field
The invention belongs to pharmaceutical fields, are related to the synthesis and application of a kind of pesticide impurities, specifically, being that 2,2- bis- is chloro- A kind of N- [2- (2- furyl) -2- hydroxyethyl] synthetic method of acetamide and the application of corresponding synthetic product.
Background technique
In the production process of drug, it is often accompanied by the generation of impurity, the yield of product is not only will affect, also will affect medicine The quality of product, and then influence the effect that drug uses.The generation of impurity during effective monitoring pharmaceutical synthesis produces guarantee The influence of quality, yield and reduction impurity to drug effectiveness plays a key role.
Furilazole (Furilazole), chemical name are as follows: 3- dichloro-acetyl -5- (2- furans) -2,2- dimethyl oxazoline Alkane, sterling are white crystal, molecular formula: C11H13Cl2NO3, molecular weight: 278.13.Structural formula is as follows:
Furilazole is a kind of novel herbicidal safener, it is used for gramineous crop in which can make many herbicide safeties, right It reduces the phyto toxicity as caused by sulfonylurea herbicide and plays useful effect, most prominent feature is can be successfully as one Serial sulfonylurea herbicide and imidazolinone herbicide use safener in the field of gramineous crop, without influencing to miscellaneous The preventive effect of grass.
And furilazole can be synthesized using following synthetic route in industrial production at present:
During being synthesized with said synthesis route, discovery final step generation has impurity 2, the chloro- N- [2- of 2- bis- (2- furyl) -2- hydroxyethyl] acetamide.The chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] second of above-mentioned generation Amide will have a direct impact on the synthesis yield of furilazole, not avoid generation 2, chloro- N- [2- (the 2- furan of 2- bis- in the prior art Mutter base) -2- hydroxyethyl] acetamide effective measures, also have no idea to detect this impurity in the product, therefore solve Careless oxazole cannot be protected to the drug effect of weeds.
Summary of the invention
The technical problem to be solved in the present invention is to provide for the chloro- N- of 2,2- of one kind bis- [2- (2- furyl) -2- hydroxyl second Base] acetamide synthetic method, be intended to using α-(amino methyl) -2- furancarbinol as raw material, under alkaline condition with dichloroacetyl Chlorine occurs acylation reaction and is made.
Another object of the present invention is to provide the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide A kind of application, it can be used as standard items, for detecting and monitoring the synthesis of furilazole.
In order to solve the above technical problems, the technical scheme adopted by the invention is that: 2,2- of one kind, bis- chloro- N- [2- (2- furans Base) -2- hydroxyethyl] acetamide synthetic method, be by α-(amino methyl) -2- furancarbinol and dichloroacetyl chloride in alkalinity Under the conditions of occur acylation reaction be made.
As limitation of the invention: the conjunction of the chloro- N- of the 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide At route are as follows:
It is limited as to another kind of the invention, the acylation reaction sequentially carries out in accordance with the following steps:
1. α-(amino methyl) -2- furancarbinol is added in solvent A, dissolves, obtain solution B;
2. acid binding agent is mixed with solution B, solution C is obtained, dichloroacetyl chloride is added dropwise after stirring a period of time and solution C is anti- It answers, obtains solution D after the reaction was completed;
3. solution D is quenched with water, it is extracted with ethyl acetate, continues to be washed with water organic phase to neutrality, concentration later is Obtain the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide crude product.
As limitation of the invention further: 3. 4. the step is additionally provided with step afterwards, it may be assumed that
4. tied using solvent E to the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide crude product again Crystalline substance dries after suction filtration, obtains the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide.
As the limiting 1. to step: the solvent A is in acetonitrile, ethyl acetate, benzene, toluene, methylene chloride, chloroform It is a kind of.
As the restriction to step 2.:
The acid binding agent is any one in ammonium hydroxide, triethylamine, pyridine, potassium carbonate, sodium hydroxide or potassium hydroxide, institute The equivalent proportion for stating acid binding agent and α-(amino methyl) -2- furancarbinol is 1~3:1;
Step 2. in, the equivalent proportion of the dichloroacetyl chloride and α-(amino methyl) -2- furancarbinol is 1~3:1;
Step 2. in, the acid binding agent is blended at a temperature of -15~25 DEG C with solution B and mixes.
As to further restriction of the invention: step 4. in, the solvent E be crystalline reagents methylene chloride, chlorine One of the mixed liquor or the aqueous solution of methanol of imitative, benzene, toluene, ethyl acetate and petroleum ether.
The present invention also provides the application of the chloro- N- of 2,2- of one kind bis- [2- (2- furyl) -2- hydroxyethyl] acetamide, institutes The chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide is stated as standard items, to detect and monitor furilazole Synthesis.
By adopting the above-described technical solution, compared with prior art, the present invention acquired technological progress is: this hair The synthetic method of bright offer is to be acylated under alkaline condition with α-(amino methyl) -2- furancarbinol with dichloroacetyl chloride Reaction is prepared the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide, separation, side is not had in reaction process Method is simple, and process is easily controllable, gained 2, and the yield of the chloro- N- of 2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide is 60 ~80%;As a kind of application of the synthesized chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide, it can It is used to detect and monitor the synthesis of furilazole as standard items.
The present invention is described in further detail below in conjunction with specific embodiment.
Detailed description of the invention
Fig. 1 is the chloro- N- of 2,2- bis- [2- (2- the furyl) -2- hydroxyethyl] acetyl synthesized in 1-7 of the embodiment of the present invention The MS of amine schemes;
Fig. 2 is the chloro- N- of 2,2- bis- [2- (2- the furyl) -2- hydroxyethyl] acetamide synthesized in inventive embodiments 1-7 's1HNMR figure;
Fig. 3 is the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide in 1-7 of the embodiment of the present invention13CNMR figure;
Fig. 4 is the DSC of the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide in 1-7 of the embodiment of the present invention Figure;
Fig. 5 is α-(nitromethyla) -2- furancarbinol in 1-7 of the embodiment of the present invention1HNMR figure;
Fig. 6 is α-(amino methyl) -2- furancarbinol in 1-7 of the embodiment of the present invention1HNMR figure;
Fig. 7 is the liquid phase figure of furilazole standard items in the embodiment of the present invention 8;
Fig. 8 is the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide standard items in the embodiment of the present invention 8 Liquid phase figure;
Fig. 9 is that the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyl second in furilazole is monitored in the embodiment of the present invention 8 Base] acetamide generate liquid phase figure;
Figure 10 is that the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyl in furilazole sterling Q is monitored in the embodiment of the present invention 8 Base ethyl] acetamide generate liquid phase figure;
Figure 11 is that the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyl in furilazole crude product P is monitored in the embodiment of the present invention 8 Base ethyl] acetamide generate liquid phase figure;
Figure 12 is bis- chloro- N- [2- (2- of 2,2- in the furilazole obtained under -15 DEG C of reaction conditions in the embodiment of the present invention 9 Furyl) -2- hydroxyethyl] acetamide generate liquid phase figure;
Figure 13 is chloro- N- [2- (the 2- furan of 2,2- bis- in the furilazole obtained under 0 DEG C of reaction condition in the embodiment of the present invention 9 Mutter base) -2- hydroxyethyl] the liquid phase figure that generates of acetamide;
Figure 14 is bis- chloro- N- [2- (2- of 2,2- in the furilazole obtained under 15 DEG C of reaction conditions in the embodiment of the present invention 9 Furyl) -2- hydroxyethyl] acetamide generate liquid phase figure.
Specific embodiment
The synthetic method of chloro- N- [2- (2- the furyl) -2- hydroxyethyl] acetamide of 1 2,2- of embodiment bis-
Synthetic method provided by the present embodiment, sequence carries out according to the following steps:
(1) preparation of raw material α-(amino methyl) -2- furancarbinol
Using 2 furan carboxyaldehyde as starting material, by condensation reaction, reduction reaction, α-(amino methyl) -2- furans is synthesized Methanol, specific synthetic route are as follows:
Synthesis, α-(amino methyl) -2- furans of α-(nitromethyla) -2- furancarbinol are contained in said synthesis route Synthesis to above two substance is illustrated by the synthesis of methanol, the present embodiment respectively.
The synthesis of α-(nitromethyla) -2- furancarbinol: 2 furan carboxyaldehyde 49.96g (i.e. 0.52mol), nitromethane are taken 158.70g (i.e. 2.6mol), barium hydroxide 8.57g (i.e. 0.05mol), water 500mL react 4h, after the reaction was completed, mistake at 25 DEG C Barium hydroxide is filtered, ethyl acetate extracts reaction solution, is concentrated after dry organic phase, obtains α-(nitromethyla) -2- furancarbinol;Institute Synthetic1HNMR figure is as shown in Figure 5.
The synthesis of α-(amino methyl) -2- furancarbinol: α-(nitromethyla) -2- furancarbinol is added in autoclave 81.37g (i.e. 0.64mol), isopropanol 500mL, 5%Pd/C 5g are (according to the 5% of α-(nitromethyla) -2- furancarbinol quality It calculates), N is used by decompression water pump after sealing2Displacement three times, is passed through the hydrogen that purity is 99.999% and replaces three times, then plus It is depressed into 10kg/cm3, 12h is reacted at 40 DEG C, and after the reaction was completed, Pd/C is filtered and recycled in slow pressure release, and filtrate is concentrated, uses acetic acid Ethyl ester recrystallizes up to α-(amino methyl) -2- furancarbinol, yield 78.9%;Synthesized substance1HNMR schemes such as Fig. 6 institute Show.
(2) acylation reaction
The reaction route of this step is as follows:
This step is successively carried out according to four substep (21)~(24):
(21) 10mL chloroform (solvent A 1) is taken, α-(the amino methyl) -2- furans of 9.90g (i.e. 0.078mol) is then added Methanol is warming up to 30~35 DEG C of dissolutions and obtains solution B 1 under stirring;
(22) solution B 1 is cooled to 0 DEG C, the sodium hydrate aqueous solution that 2.09mL concentration is 33% is added, and (sodium hydroxide has Effect ingredient is 6.90g, that is, 0.173mol), solution C 1 is obtained after stirring 10min, then by two chloroethene of 15.06g (i.e. 0.10mol) Acyl chlorides is added drop-wise in solution C 1, continues to react at a temperature of 0 DEG C to complete, obtained solution D1 after being added dropwise;
(23) after the reaction was completed, solution D 1 is quenched with water, then successively carries out ethyl acetate extraction, washing, dense Contracting is to get the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide solid crude product;
(24) above-mentioned crude product is recrystallized using methylene chloride, and dried after filtering to get the chloro- N- [2- of 2,2- bis- (2- furyl) -2- hydroxyethyl] acetamide, the MS figure of synthetic,1HNMR、13CNMR figure, DSC figure see respectively as Fig. 1~ Fig. 4.
The synthetic method of the chloro- N- of embodiment 2-7 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide
Embodiment 2-7 is respectively the synthesis side of a kind of chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide The synthetic method difference of method, they and embodiment 1 is essentially identical, the difference is that only in following table between listed procedure parameter not Together, the amount of substance is in addition generated also different (being not shown in table).
Table 1
The application of chloro- N- [2- (2- the furyl) -2- hydroxyethyl] acetamide of 8 2,2- of embodiment bis-
(1) firstly, under -15~15 DEG C of temperature environment, furilazole is synthesized with following synthetic route:
The furilazole crude product of synthesis is denoted as P.P is purified by ethyl alcohol recrystallization, is obtained sterling furilazole, is denoted as Q.
(2) then, with the chloro- N- of 2,2- bis- prepared by embodiment 1-7 [2- (2- furyl) -2- hydroxyethyl] acetyl Amine is disliked as standard reference material by the comparison chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide reconciliation grass It whether there is 2,2- bis- during synthesis furilazole involved in the liquid phase figure detecting step (one) of azoles and in final product Chloro- N- [2- (2- furyl) -2- hydroxyethyl] acetamide and contained amount are how many, realize to furilazole synthesis process Monitoring.
The monitoring process of furilazole are as follows: precision weighs furilazole mark product 0.015g (being accurate to 0.001g), is dissolved in In methanol, shake up;It is (accurate that precision weighs the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide mark product 0.015g It to 0.001g), is dissolved in methanol, shakes up.Under the chromatographic condition set: mobile phase as methanol-water (volume ratio 75: 35), flow velocity 1.0mL/min, column temperature are set as 30 DEG C, sample volume 0.025mL, Detection wavelength 218nm.Respectively to solution grass Oxazole mark product and 2, the chloro- N- of 2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide mark product are detected, furilazole mark product Retention time be 4.730min, purity 99.850%;The chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide The retention time of mark product is 3.030min, purity 99.755%.
Under identical chromatographic conditions, furilazole crude product P is detected, the peak that retention time is 4.730min is solution grass Oxazole, content 89.463%;The peak that retention time is 3.030min is the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyl second Base] acetamide, content 10.537% is shown in Fig. 9.
The application of chloro- N- [2- (2- the furyl) -2- hydroxyethyl] acetamide of 9 2,2- of example bis-
With under identical high-efficient liquid phase chromatogram condition in example 8, in example 8 recrystallize after furilazole sterling Q into Row detection, the peak that retention time is 4.730min is furilazole, content 99.985%;Retention time is the peak of 3.030min For the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide, content 0.015% is shown in Figure 10.
The application of chloro- N- [2- (2- the furyl) -2- hydroxyethyl] acetamide of 10 2,2- of example bis-
With under identical high-efficient liquid phase chromatogram condition in example 8, to the furilazole crude product P not recrystallized in example 8 It is detected, the peak that retention time is 4.730min is furilazole, content 79.865%;Retention time is 3.030min's Peak is the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide, and content 20.135% is shown in Figure 11.
The application of chloro- N- [2- (2- the furyl) -2- hydroxyethyl] acetamide of 11 2,2- of example bis-
It, can be by the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetyl during synthesizing furilazole Amine is used as the generation situation that standard items detected and monitored this impurity, this is significant to the improvement of reaction condition.
In the case where other conditions are constant, change reaction temperature, synthesizes solution under the conditions of -15 DEG C, 0 DEG C, 15 DEG C respectively Careless oxazole crude product, specific operating method is identical as example 8, detects to obtained furilazole crude product P1, P2, P3. Efficient liquid-phase chromatography method and example 8 are consistent.Testing result is as follows:
In the furilazole crude product P1 liquid phase figure reacted at -15 DEG C, the peak of retention time 4.730min is solution grass Oxazole, content 94.038%;The peak of retention time 3.030min is the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyl second Base] acetamide, content 5.962% is shown in Figure 12;
In the furilazole crude product P2 liquid phase figure reacted at 0 DEG C, the peak of retention time 4.730min is that solution grass is disliked Azoles, content 85.457%;The peak of retention time 3.030min is the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] Acetamide, content 14.543%, is shown in Figure 13;
In the furilazole crude product P3 liquid phase figure reacted at 15 DEG C, the peak of retention time 4.730min is that solution grass is disliked Azoles, content 69.998%;The peak of retention time 3.030min is the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] Acetamide, content 30.002%, is shown in Figure 14.
According to above-mentioned liquid phase result it is found that being reacted at -15 DEG C in resulting furilazole crude product P1, furilazole contains Highest is measured, the content of 2,2- bis- chloro- N- [2- (2- furyl) -2- hydroxyethyl] acetamides is minimum, so in three temperature strips Under part, -15 DEG C are optimal reaction temperature.
Therefore, by furilazole crude product P1, P2, the P3 obtained under different condition, in identical high performance liquid chromatography Under the conditions of carry out furilazole and 2, the detection of the chloro- N- of 2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide can filter out The content of optimal reaction condition, the i.e. chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide is lower, solves grass and dislikes The yield of azoles is higher, then reaction condition is better.
Embodiment 1-11, is only presently preferred embodiments of the present invention, is not the restriction of other forms made for the present invention, Any person skilled in the art cannot be changed or be modified as equivalent variations using above-mentioned technology contents as enlightenment Equivalent embodiment, but all technical spirits without departing from the claims in the present invention simply repair to made by above embodiments Change, equivalent variations and remodeling, still falls within the range of the claims in the present invention protection.

Claims (10)

1. one kind 2, the synthetic method of the chloro- N- of 2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide, it is characterised in that: be Acylation reaction is occurred under alkaline condition for α-(amino methyl) -2- furancarbinol and dichloroacetyl chloride to be made.
The synthesis side of the chloro- N- of 2,2- bis- according to claim 1 2. [2- (2- furyl) -2- hydroxyethyl] acetamide Method, it is characterised in that:
The synthetic line of the chloro- N- of the 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide are as follows:
The synthesis of the chloro- N- of 2,2- bis- according to claim 1 or 2 3. [2- (2- furyl) -2- hydroxyethyl] acetamide Method, it is characterised in that: the acylation reaction sequentially carries out in accordance with the following steps:
1. α-(amino methyl) -2- furancarbinol is added in solvent A, dissolves, obtain solution B;
2. acid binding agent is mixed with solution B, solution C is obtained, is stirred, dichloroacetyl chloride is added dropwise, obtains solution D after the reaction was completed;
3. solution D is quenched with water, it is extracted with ethyl acetate, continues to be washed with water organic phase to neutrality, up to 2,2- after concentration Two chloro- N- [2- (2- furyl) -2- hydroxyethyl] acetamide crude products.
The synthesis side of the chloro- N- of 2,2- bis- according to claim 3 4. [2- (2- furyl) -2- hydroxyethyl] acetamide Method, it is characterised in that: the 3. 4. step is additionally provided with step afterwards, it may be assumed that
4. being recrystallized using solvent E to the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide crude product, take out It is dried after filter, obtains the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide.
The synthesis side of the chloro- N- of 2,2- bis- according to claim 3 5. [2- (2- furyl) -2- hydroxyethyl] acetamide Method, it is characterised in that: step 1. in, the solvent A be acetonitrile, ethyl acetate, benzene, toluene, methylene chloride or chloroform in one Kind.
The synthesis side of the chloro- N- of 2,2- bis- according to claim 3 6. [2- (2- furyl) -2- hydroxyethyl] acetamide Method, it is characterised in that: step 2. in, the acid binding agent be ammonium hydroxide, triethylamine, pyridine, potassium carbonate, sodium hydroxide or potassium hydroxide In any one, the equivalent proportion of the acid binding agent and α-(amino methyl) -2- furancarbinol is 1~3:1.
The synthesis side of the chloro- N- of 2,2- bis- according to claim 3 7. [2- (2- furyl) -2- hydroxyethyl] acetamide Method, it is characterised in that: step 2. in, the equivalent proportion of the dichloroacetyl chloride and α-(amino methyl) -2- furancarbinol is 1~3: 1。
The synthesis side of the chloro- N- of 2,2- bis- according to claim 3 8. [2- (2- furyl) -2- hydroxyethyl] acetamide Method, it is characterised in that: step 2. in, the acid binding agent and solution B -15~25 DEG C at a temperature of mix.
The synthesis side of the chloro- N- of 2,2- bis- according to claim 4 9. [2- (2- furyl) -2- hydroxyethyl] acetamide Method, it is characterised in that: step 4. in, the solvent E be crystalline reagents methylene chloride, chloroform, benzene, toluene, ethyl acetate and stone One of mixed liquor or the aqueous solution of methanol of oily ether.
A kind of application of 10.2,2- bis- chloro- N- [2- (2- furyl) -2- hydroxyethyl] acetamides, it is characterised in that: described 2, The chloro- N- of 2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide is used as standard items, to detect and monitor the conjunction of furilazole At.
CN201910394987.2A 2019-05-13 2019-05-13 The synthetic method and its application of the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide Pending CN110041294A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910394987.2A CN110041294A (en) 2019-05-13 2019-05-13 The synthetic method and its application of the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910394987.2A CN110041294A (en) 2019-05-13 2019-05-13 The synthetic method and its application of the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide

Publications (1)

Publication Number Publication Date
CN110041294A true CN110041294A (en) 2019-07-23

Family

ID=67281719

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910394987.2A Pending CN110041294A (en) 2019-05-13 2019-05-13 The synthetic method and its application of the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide

Country Status (1)

Country Link
CN (1) CN110041294A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114989115A (en) * 2022-07-01 2022-09-02 河北科技大学 Improved synthesis of alpha- (nitromethyl) -2-furancarbinols and method for maintaining catalyst activity in such a process

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101235024A (en) * 2008-02-01 2008-08-06 中国科学院上海有机化学研究所 Benzodihydropyrane compounds, synthesizing method and use thereof
CN102060719A (en) * 2011-01-07 2011-05-18 天津市炜杰科技有限公司 Method for preparing midodrine hydrochloride intermediate 1-(2,5-dimethoxy benzaldehyde)-2-aminoethanol
CN102617560A (en) * 2011-01-30 2012-08-01 南京理工大学 Preparation method of furilazole
CN106674213A (en) * 2015-11-06 2017-05-17 南通德益化工有限公司 Preparation method of furilazole

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101235024A (en) * 2008-02-01 2008-08-06 中国科学院上海有机化学研究所 Benzodihydropyrane compounds, synthesizing method and use thereof
CN102060719A (en) * 2011-01-07 2011-05-18 天津市炜杰科技有限公司 Method for preparing midodrine hydrochloride intermediate 1-(2,5-dimethoxy benzaldehyde)-2-aminoethanol
CN102617560A (en) * 2011-01-30 2012-08-01 南京理工大学 Preparation method of furilazole
CN106674213A (en) * 2015-11-06 2017-05-17 南通德益化工有限公司 Preparation method of furilazole

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FEI YE等: ""A convenient one-pot synthesis and bioactivity of N-dichloroacetyl-5-aryl-1,3- oxazolidines"", 《HETEROCYCLIC COMMUNICATIONS》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114989115A (en) * 2022-07-01 2022-09-02 河北科技大学 Improved synthesis of alpha- (nitromethyl) -2-furancarbinols and method for maintaining catalyst activity in such a process
CN114989115B (en) * 2022-07-01 2024-04-30 兰升生物科技集团股份有限公司 Improved synthesis of alpha- (nitromethyl) -2-furanmethanol and method for maintaining catalyst activity in the process

Similar Documents

Publication Publication Date Title
JP6861858B2 (en) SSAO inhibitor
DE60023841T2 (en) PROCESS FOR PREPARING ALKYLATED SALICYLAMIDE
CN102209707B (en) Novel process for the preparation of amino acid derivatives
CN107033087B (en) 1H-indazole-4-amine compounds and use thereof as IDO inhibitors
TWI230162B (en) Geranyl group-containing compounds
BRPI0718988A2 (en) METHOD FOR PREPARING A PHENYLALANINE DERIVATIVE AND, COMPOSITE
CN101801918A (en) Monoamide derivatives as orexin receptor antagonists
CN112839942A (en) 1,3, 4-oxadiazole derivative compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same
CN107880040A (en) A kind of tetrahydro-b-carboline analog derivative and preparation method thereof and purposes
JP7136527B2 (en) 3-[(3S)-7-bromo-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-[1,4]-benzodiazepin-3-yl]propionic acid methyl ester Method of preparation and compounds useful in the method
CA3197619A1 (en) Benzylamine or benzyl alcohol derivative and use thereof
JP2017518272A (en) Process for the preparation of substituted cycloserine
CN103848795B (en) A kind of 1,2,5-diazole-2-oxide Antibiotic FR 901228 and its preparation method and application
JPS5962555A (en) Omega-amino acid derivative
CN110041294A (en) The synthetic method and its application of the chloro- N- of 2,2- bis- [2- (2- furyl) -2- hydroxyethyl] acetamide
CN117120421A (en) 1,3, 4-oxadiazole thiocarbonyl compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions containing the same
CN102070576A (en) 1-indanone-3-acetic acid compound as well as preparation method and application of 1-indanone-3-acetic acid compound
JP2023516102A (en) 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitors, and pharmaceutical compositions containing the same
CN106800589B (en) Cyclic peptide compounds, preparation method, pharmaceutical composition and application thereof
Meiresonne et al. Synthesis of novel β-aminocyclobutanecarboxylic acid derivatives by a solvent-free aza–Michael addition and subsequent ring closure
CN113214238B (en) Preparation and application of indole oxadiazole derivative with acylated piperazine structure
CN107778224B (en) Preparation method of betrixaban intermediate
CN111471041B (en) Synthetic method of oxazolidinone antibacterial drug intermediate
CN102532059A (en) Application of naphtho-[1, 2 and 3] benzothiadiazola fluorine containing derivative serving as plant disease-resistant activating agent
CN101654426B (en) Method for preparing ilomastat

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination